Jasper Therapeutics Inc (JSPR)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-12-12 | 2024-12-12 | PS Planned sale |
Chief Operating Officer Officer |
900
-3.5%
22.11USD 19,899 |
900 -3.5% | 22.11 | USD 19,899 | |
| 2024-09-12 | 2024-09-12 | PS Planned sale |
Chief Operating Officer Officer |
900
-3.5%
21.23USD 19,104 |
900 -3.5% | 21.23 | USD 19,104 | |
| 2024-06-12 | 2024-06-12 | PS Planned sale |
Chief Operating Officer Officer |
900
-3.5%
24.16USD 21,740 |
900 -3.5% | 24.16 | USD 21,740 | |
| 2024-03-12 | 2024-03-12 | PS Planned sale |
Chief Operating Officer Officer |
900
-3.5%
26.44USD 23,792 |
900 -3.5% | 26.44 | USD 23,792 | |
| 2024-02-12 | 2024-02-08 | B Purchase |
Former 10% Owner |
190,000
+21.7%
12.95USD 2,460,500 |
190,000 +21.7% | 12.95 | USD 2,460,500 | |
| 2024-02-09 | 2024-02-08 | B Purchase |
Velan Capital Investment Management LP Large shareholder |
350,000
+41.7%
12.95USD 4,532,500 |
350,000 +41.7% | 12.95 | USD 4,532,500 | |
| 2023-11-30 | 2023-11-28 | B Purchase | Non-Executive Director |
10,000
+25.0%
0.65USD 6,486 |
10,000 +25.0% | 0.65 | USD 6,486 | |
| 2023-11-22 | 2023-11-21 | B Purchase | Non-Executive Director |
10,000
+33.3%
0.64USD 6,383 |
10,000 +33.3% | 0.64 | USD 6,383 | |
| 2023-11-20 | 2023-11-20 | B Purchase | Non-Executive Director |
10,000
+50.0%
0.63USD 6,309 |
10,000 +50.0% | 0.63 | USD 6,309 | |
| 2023-11-20 | 2023-11-17 | B Purchase | Non-Executive Director |
10,000
+100.0%
0.60USD 5,966 |
10,000 +100.0% | 0.60 | USD 5,966 | |
| 2023-11-20 | 2023-11-16 | B Purchase | Non-Executive Director |
10,000
+inf%
0.60USD 5,965 |
10,000 +inf% | 0.60 | USD 5,965 | |
| 2023-10-13 | 2023-10-13 | PS Planned sale | Non-Executive Director |
7,965
-13.0%
0.85USD 6,777 |
7,965 -13.0% | 0.85 | USD 6,777 | |
| 2023-06-13 | 2023-06-13 | PS Planned sale |
See Remarks Officer |
9,000
-3.0%
1.66USD 14,915 |
9,000 -3.0% | 1.66 | USD 14,915 | |
| 2023-04-14 | 2023-04-14 | S Sale | Non-Executive Director |
7,000
-22.8%
1.48USD 10,360 |
7,000 -22.8% | 1.48 | USD 10,360 | |
| 2023-04-14 | 2023-04-13 | S Sale | Non-Executive Director |
9,075
-30.0%
1.49USD 13,524 |
9,075 -30.0% | 1.49 | USD 13,524 | |
| 2023-04-14 | 2023-04-13 | S Sale | Non-Executive Director |
8,500
-12.1%
1.44USD 12,240 |
8,500 -12.1% | 1.44 | USD 12,240 | |
| 2023-04-11 | 2023-01-27 | B Purchase |
Qiming U.S. Healthcare Fund II, L.P. Large shareholder |
2,666,666
+45.6%
1.50USD 3,999,999 |
2,666,666 +45.6% | 1.50 | USD 3,999,999 | |
| 2023-01-31 | 2023-01-27 | B Purchase | Large shareholder |
3,133,333
+55.7%
1.50USD 4,700,000 |
3,133,333 +55.7% | 1.50 | USD 4,700,000 | |
| 2023-01-26 | 2023-01-25 | S Sale | Large shareholder |
75,000
-1.6%
1.89USD 141,750 |
75,000 -1.6% | 1.89 | USD 141,750 | |
| 2022-06-28 | 2022-06-27 | PS Planned sale | Non-Executive Director |
24,743
-37.9%
2.08USD 51,404 |
24,743 -37.9% | 2.08 | USD 51,404 |